ORCID as entered in ROS

Select Publications
2025, 'Surgical outcomes in high-grade adult type diffuse gliomas (ATDG) with a previous diagnosis of anaplastic astrocytoma without adjuvant therapy', Clinical Neurology and Neurosurgery, 253, pp. 108879, http://dx.doi.org/10.1016/j.clineuro.2025.108879
,2024, 'EXTH-10. TARGETING EPHA3 AND EPHRIN A5: ADVANCED PRECISION THERAPY FOR GBM', Neuro-Oncology, 26, pp. viii238 - viii238, http://dx.doi.org/10.1093/neuonc/noae165.0941
,2024, 'STEM-01. SHARED ASTROCYTE-LIKE GLIOMA STEM CELLS DRIVE HETEROGENEITY AND IMMUNE DYNAMICS IN ADULT-TYPE DIFFUSE GLIOMAS', Neuro-Oncology, 26, pp. viii57 - viii57, http://dx.doi.org/10.1093/neuonc/noae165.0227
,2024, 'A BRAIN CANCER CELL ATLAS REVEALS SHARED ASTROCYTE-LIKE STEM CELL STATES DRIVE INTRATUMOURAL HETEROGENEITY AND SHAPE IMMUNE DYNAMICS IN ADULT-TYPE DIFFUSE GLIOMAS', NEURO-ONCOLOGY, 26, pp. V3 - V3, http://dx.doi.org/10.1093/neuonc/noae144.007
,2022, 'Endoscopic-assisted surgical approach for butterfly glioma surgery', Journal of Neuro Oncology, 156, pp. 635 - 644, http://dx.doi.org/10.1007/s11060-022-03945-5
,2021, 'Podnl1 methylation serves as a prognostic biomarker and associates with immune cell infiltration and immune checkpoint blockade response in lower-grade glioma', International Journal of Molecular Sciences, 22, pp. 12572, http://dx.doi.org/10.3390/ijms222212572
,2021, 'Charlie Teo Foundation brain tumour bank', Open Journal of Bioresources, 8, pp. 1 - 8, http://dx.doi.org/10.5334/OJB.76
,2019, 'Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)', Scientific Reports, 9, pp. 2905, http://dx.doi.org/10.1038/s41598-019-39427-4
,2016, 'TMOD-14. ESTABLISHMENT AND MOLECULAR CHARACTERIZATION OF PATIENT DERIVED CELL LINES FROM LOW GRADE GLIOMA', Neuro-Oncology, 18, pp. vi209 - vi210, http://dx.doi.org/10.1093/neuonc/now212.884
,2024, 'EXPLORING THE ROLE OF ANDROGEN RECEPTOR SIGNALING IN GLIOBLASTOMA IN AN ORTHOTOPIC ANIMAL MODEL', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, TX, Houston, presented at 29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), TX, Houston, 21 November 2024 - 24 November 2024, http://dx.doi.org/10.1093/neuonc/noae165.0957
,2016, 'ESTABLISHMENT AND MOLECULAR CHARACTERIZATION OF PATIENT DERIVED CELL LINES FROM LOW GRADE GLIOMA', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, AZ, Scottsdale, pp. 209 - 210, presented at 21st Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology, AZ, Scottsdale, 17 November 2016 - 20 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398604104194&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2025, A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours, http://dx.doi.org/10.1101/2025.02.03.25321619
,2024, Adult-type diffuse gliomas share recurring cell states driven by a common astrocyte-like glioma stem cell population, http://dx.doi.org/10.1101/2024.06.13.598923
,